FDA Inspection 1209032 — Latvijas Organiskas sintezes instituts
The FDA completed an inspection of Latvijas Organiskas sintezes instituts on March 29, 2023 in Riga. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Riga (Latvia)
Additional Details
Mutual Recognition Agreement (MRA)